Schizophrenia 3
MONDO:0010897A schizophrenia that has material basis in an autosomal dominant mutation of SCZD3 on chromosome 6p23.
Also known as: SCZD3, schizophrenia 3, schizophrenia 3 with or without an affective disorder, schizophrenia susceptibility locus, chromosome 6-related
72 clinical trials for this condition and its sub-types, 0 tagged with Schizophrenia 3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Can a diabetes drug beat metformin for antipsychotic weight gain?
Disease control Not yet recruitingThis study compares dapagliflozin and metformin for managing weight gain caused by antipsychotic medications. About 110 adults aged 16 and older will take one of the drugs plus lifestyle advice for 26 weeks. The goal is to see which drug works better and is safer for weight contr…
Phase 4 • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Online mood booster tested for schizophrenia motivation
Symptom relief Not yet recruitingThis study tests a 12-week online program designed to improve mood and motivation in people with schizophrenia or early psychosis. Participants complete 20-30 minute weekly sessions. Researchers will measure changes in symptoms and goal-directed behavior before and after the prog…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Virtual reality therapy could help psychosis patients tame overwhelming emotions
Symptom relief Not yet recruitingThis study tests a new therapy that combines face-to-face sessions with virtual reality (VR) to help people with psychosis manage their emotions. Participants will practice emotion regulation skills in realistic VR scenarios with live coaching from a therapist. Fifteen people wit…
Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Talking through trauma: new therapy tested for psychosis relief
Symptom relief Not yet recruitingThis study tests whether a type of talk therapy called narrative exposure therapy (NET) is practical and helpful for people with psychosis who have experienced trauma. One participant will receive NET sessions and complete questionnaires about their symptoms and experiences. The …
Sponsor: University of Nottingham • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can a buddy system help veteran moms with mental illness?
Symptom relief Not yet recruitingThis study aims to see if peer support can help pregnant and postpartum veterans who have serious mental illness. Researchers will develop a program where trained peer specialists offer support, then test it with 24 veterans to see if it is helpful and practical. The goal is to i…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Scientists build a computer model of the brain to explain hearing voices
Knowledge-focused Not yet recruitingResearchers at King's College London are studying what happens in the brain when people hear voices or sounds others cannot hear, known as auditory hallucinations. The study compares people with schizophrenia, schizoaffective disorder, or related psychotic conditions to people wi…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can education change how schizophrenia patients view their meds?
Knowledge-focused Not yet recruitingThis study will test whether educational sessions can improve health literacy and attitudes toward medication in 34 adults hospitalized with schizophrenia or related disorders. Participants will receive pamphlets and watch videos about their condition, then complete questionnaire…
Sponsor: Louisiana State University Health Sciences Center in New Orleans • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Your life story may predict mental health recovery, study suggests
Knowledge-focused Not yet recruitingThis study looks at how people with a first episode of psychosis tell their life stories and whether that relates to their well-being and recovery. Researchers will compare 96 participants—those with early psychosis, those with chronic psychosis, and healthy controls—using questi…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC